CROs/Service Providers

Report: INC Research to close clinical unit in W. Virginia

Thursday, April 26, 2012 03:01 PM

INC Research of Raleigh, N.C., confirmed it is closing its clinical study unit in Morgantown, W.V., according to an online report in The State Journal.

More... »

Icon reports 10% increase in Q1 2012

Wednesday, April 25, 2012 09:45 AM

Icon, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has released its first quarter financial results for 2012, reporting its Q1 net revenues grew 10% year on year to $252.3 million from $229.3 million in Q1 2011.

More... »

Cetero reaches final resolution with FDA

Tuesday, April 24, 2012 03:10 PM

Cary, N.C.-based CRO Cetero Research has reached a final resolution with the FDA over studies the company conducted in its Houston bioanalytical laboratory between April 1, 2005 and June 15, 2010. Following months of open collaboration between Cetero and the agency, the FDA summarized its final decision:

More... »

Iris Pharma, RxGen form strategic alliance

Tuesday, April 24, 2012 12:15 PM

Iris Pharma of France, an ophthalmic preclinical and clinical CRO, and RxGen, a Connecticut-based specialty preclinical CRO focused on the development and application of translational research models, have formed a strategic alliance to offer fully integrated “bench-to-bedside” ophthalmology research services.

More... »

NextBio expands into translational medicine applications

Monday, April 23, 2012 02:47 PM

NextBio of Santa Clara, Calif., has unveiled NextBio Clinical, an extension of the company's existing life sciences platform to translational medicine applications such as biomarker discovery and clinical trial optimization.

More... »

HGS refuses GSK unsolicited offer, considers alternatives

Friday, April 20, 2012 11:21 AM

Human Genome Sciences has refused GlaxoSmithKline’s unsolicited offer on April 11 proposing to acquire all of the outstanding shares of HGS for $13.00 per share in cash ($2.6 billion), an 81% premium to closing share price on April 18.

More... »

INC Research, Astellas form multi-year development alliance

Wednesday, April 18, 2012 11:04 AM

INC Research, a therapeutically focused CRO, has entered into a Functional Service Provider (FSP) alliance with Astellas Pharma to drive global consistency, save time and reduce costs for multiple clinical development programs across several therapeutic areas.

More... »

AMRI and Biota strike development and manufacturing deal

Wednesday, April 18, 2012 09:44 AM

AMRI, a global contract research and manufacturing organization, was selected by Biota Holdings, an Australian anti-infective drug development company, to further develop and manufacture influenza antiviral CS8958 (laninamivir), a second-generation, long-acting neuraminidase inhibitor.

More... »

MDI completes $1.9M Series B financing for Detect-Ready tests

Tuesday, April 17, 2012 07:30 AM

Molecular Detection Inc. (MDI), a Berwyn, Penn.-based company developing Detect-Ready tests designed to increase the speed and accuracy of infectious disease diagnosis, has completed a $1.9 million Series B recapitalization financing. 

More... »

BASF and Catalent aim to solve bioavailability challenges

Friday, April 6, 2012 12:36 PM

Catalent Pharma Solutions, a services and solutions provider, and BASF, a leading chemical company, have formed an open alliance to provide solutions to overcome bioavailability challenges of new molecular entities with solubility or permeability challenges. 

More... »